Dojolvi Disease Interactions
There is 1 disease interaction with Dojolvi (triheptanoin).
Moderate
Triheptanoin (applies to Dojolvi) pancreatic insufficiency
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Pancreatitis, Diabetes Mellitus, Cystic Fibrosis
Avoid the administration of triheptanoin in patients with pancreatic insufficiency as reduced absorption will lead to insufficient supplementation.
Switch to professional interaction data
Dojolvi drug interactions
There is 1 drug interaction with Dojolvi (triheptanoin).
Report options
QR code containing a link to this page
More about Dojolvi (triheptanoin)
- Dojolvi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: oral nutritional supplements
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Featured
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Reviews & ratings
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
